Literature DB >> 11588554

Primary protein-losing enteropathy in anti-double-stranded DNA disease: the initial and sole clinical manifestation of occult systemic lupus erythematosus?

K A Northcott1, E M Yoshida, U P Steinbrecher.   

Abstract

Hypoalbuminemia and generalized edema is a common clinical problem and the etiology is usually clear: cirrhosis, nephrotic syndrome, primary gastrointestinal disorders, malnutrition, etc. We present a 23-year-old previously healthy woman of Korean background who presented with generalized edema and a serum albumin of 9 g/L (normal, 35-45 g/L). Intensive investigations failed to reveal liver, renal, or inflammatory gastrointestinal mucosal disease. The antinuclear antibody was positive at a titer of 1:80, and extractable nuclear antigens were positive for SSA/anti-Ro. Anti-double-stranded DNA was markedly elevated at 4.6 kU/L (normal, 0-2.0 kU/L). A technetium 99M-labeled albumin study revealed a protein-losing enteropathy, despite normal histologic full-thickness jejunal biopsies. A diagnosis of occult systemic lupus erythematosus resulting in increased intestinal vascular permeability was made. The hypoalbuminemia remained in long-term remission after the initiation of induction and maintenance immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588554     DOI: 10.1097/00004836-200110000-00019

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

Review 1.  Lupus protein-losing enteropathy (LUPLE): a systematic review.

Authors:  Sultan M Al-Mogairen
Journal:  Rheumatol Int       Date:  2011-02-23       Impact factor: 2.631

2.  [Protein-losing enteropathy: a cause of hypoalbuminaemia in patients with systemic lupus erythematosus].

Authors:  P Xanthouli; H Mühleisen; S Briem; D Weis; C Fiehn
Journal:  Z Rheumatol       Date:  2011-04       Impact factor: 1.372

3.  Protein-losing enteropathy associated with systemic lupus erythematosus: response to cyclophosphamide.

Authors:  Gláucio R Werner de Castro; Simone Appenzeller; Manoel B Bértolo; Lílian Tereza Lavras Costallat
Journal:  Rheumatol Int       Date:  2004-07-13       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.